{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:59:59Z","timestamp":1770983999323,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2021,11,30]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p> Ivermectin is widely used for the treatment of neglected tropical diseases\nassociated with adverse maternal and fetal outcomes when the infection complicates the pregnancy.\nHowever, the United States FDA classification and current distribution protocols limit\nivermectin treatment in pregnant women because antepartum safety has not been well-established.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>We conducted a scoping review to address the question of what is known from both human\nand vertebrate animal studies about the safety of systemic ivermectin exposure during pregnancy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> We searched PubMed for adverse outcomes related to systemic ivermectin exposure in\nhuman and vertebrate animal pregnancies, including English-language primary articles from 1900 -\n2019.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>We identified 23 primary articles for evaluation, including 10 human studies and 13 vertebrate\nanimal studies of interest. One prospective randomized, controlled trial investigating the safety\nof systemic ivermectin exposure during pregnancy and four retrospective human studies did not\nidentify a significant association with adverse birth outcome metrics. Out of the three human case\nreports, two reported uncomplicated prenatal courses and one reported stillbirth and maternal\ndeath. A retrospective cross-sectional study concluded a positive association between onchocerciasis\nand spontaneous abortion, mitigated by ivermectin mass drug administration. While adverse\npregnancy outcomes were observed at high doses in mice, rats, and rabbits, there was overall a lack\nof evidence to support concerns that therapeutic doses of ivermectin (0.2 mg\/kg) cause adverse\npregnancy outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Further research is warranted to address safety concerns regarding the use of\nivermectin in pregnant women in treating and preventing neglected helminth infections that threaten\nmaternal-child health.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886315999200820125001","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T05:12:12Z","timestamp":1598332332000},"page":"299-308","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating the Risks of Systemic Maternal Ivermectin Exposure During Pregnancy in Human and Vertebrate Animals: A Scoping Review"],"prefix":"10.2174","volume":"16","author":[{"given":"Camille S.","family":"Westlake","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4587-6121","authenticated-orcid":true,"given":"David M.","family":"Aronoff","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/185141","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/185141\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/185141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T09:50:50Z","timestamp":1639561850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/185141\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,11,30]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886315999200820125001","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-04-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}